These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10762456)

  • 1. Heterogeneity of autoantibodies against cardiolipin and oxidatively modified LDLs revealed by human monoclonal antibodies.
    Lefvert AK
    J Intern Med; 2000 Mar; 247(3):385-90. PubMed ID: 10762456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-apolipoprotein A-I autoantibody: characterization of monoclonal autoantibodies from patients with systemic lupus erythematosus.
    Abe H; Tsuboi N; Suzuki S; Sakuraba H; Takanashi H; Tahara K; Tonozuka N; Hayashi T; Umeda M
    J Rheumatol; 2001 May; 28(5):990-5. PubMed ID: 11361227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating autoantibodies recognizing peroxidase-oxidized low density lipoprotein. Evidence for new antigenic epitopes formed in vivo independently from lipid peroxidation.
    Seccia M; Albano E; Maggi E; Bellomo G
    Arterioscler Thromb Vasc Biol; 1997 Jan; 17(1):134-40. PubMed ID: 9012648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating autoantibodies to oxidized cardiolipin correlate with isoprostane F(2alpha)-VI levels and the extent of atherosclerosis in ApoE-deficient mice: modulation by vitamin E.
    Praticò D; Tangirala RK; Hörkkö S; Witztum JL; Palinski W; FitzGerald GA
    Blood; 2001 Jan; 97(2):459-64. PubMed ID: 11154223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies against cardiolipin and oxidatively modified LDL in 50-year-old men predict myocardial infarction.
    Wu R; Nityanand S; Berglund L; Lithell H; Holm G; Lefvert AK
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3159-63. PubMed ID: 9409306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and characterization of two human monoclonal anti-phospholipid IgG from patients with autoimmune disease.
    von Landenberg C; Lackner KJ; von Landenberg P; Lang B; Schmitz G
    J Autoimmun; 1999 Sep; 13(2):215-23. PubMed ID: 10479390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A common anti-cardiolipin antibody idiotype in autoimmune disease: identification using a mouse monoclonal antibody directed against a naturally-occurring anti-phospholipid antibody.
    Sutjita M; Hohmann A; Comacchio R; Boey ML; Bradley J
    Clin Exp Immunol; 1989 Feb; 75(2):211-6. PubMed ID: 2784733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies to modified LDLs and other phospholipid-protein complexes as markers of cardiovascular diseases.
    Vaarala O
    J Intern Med; 2000 Mar; 247(3):381-4. PubMed ID: 10762455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal anti-cardiolipin antibodies bind to DNA.
    Rauch J; Tannenbaum H; Stollar BD; Schwartz RS
    Eur J Immunol; 1984 Jun; 14(6):529-34. PubMed ID: 6203756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding parameters and idiotypic profile of the whole immunoglobulin and Fab' fragments of murine monoclonal antibody to distinct determinants of the human high molecular weight-melanoma associated antigen.
    Temponi M; Gold AM; Ferrone S
    Cancer Res; 1992 May; 52(9):2497-503. PubMed ID: 1373670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune responses to oxidative neoepitopes on LDL and phospholipids modulate the development of atherosclerosis.
    Palinski W; Witztum JL
    J Intern Med; 2000 Mar; 247(3):371-80. PubMed ID: 10762454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal IgM rheumatoid factors derived from arthritic MRL/Mp-lpr/lpr mice.
    Theofilopoulos AN; Balderas RS; Hang L; Dixon FJ
    J Exp Med; 1983 Sep; 158(3):901-19. PubMed ID: 6224885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human-derived anti-oxidized LDL autoantibody blocks uptake of oxidized LDL by macrophages and localizes to atherosclerotic lesions in vivo.
    Shaw PX; Hörkkö S; Tsimikas S; Chang MK; Palinski W; Silverman GJ; Chen PP; Witztum JL
    Arterioscler Thromb Vasc Biol; 2001 Aug; 21(8):1333-9. PubMed ID: 11498462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased levels of autoantibodies against copper-oxidized low density lipoprotein, malondialdehyde-modified low density lipoprotein and cardiolipin in patients with rheumatoid arthritis.
    Cvetkovic JT; Wållberg-Jonsson S; Ahmed E; Rantapää-Dahlqvist S; Lefvert AK
    Rheumatology (Oxford); 2002 Sep; 41(9):988-95. PubMed ID: 12209031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma.
    Palinski W; Hörkkö S; Miller E; Steinbrecher UP; Powell HC; Curtiss LK; Witztum JL
    J Clin Invest; 1996 Aug; 98(3):800-14. PubMed ID: 8698873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies against oxidized LDL--theory and clinical use.
    Steinerová A; Racek J; Stozický F; Zima T; Fialová L; Lapin A
    Physiol Res; 2001; 50(2):131-41. PubMed ID: 11522041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiolipin binding a light chain from lupus-prone mice.
    Pereira B; Benedict CR; Le A; Shapiro SS; Thiagarajan P
    Biochemistry; 1998 Feb; 37(5):1430-7. PubMed ID: 9477972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of monoclonal antibodies to identify shared idiotypes on anticardiolipin and anti-DNA antibodies in human sera.
    Valesini G; Tincani A; Harris EN; Mantelli PG; Allegri F; Palmieri G; Hughes GR; Balsano F; Balestrieri G
    Clin Exp Immunol; 1987 Oct; 70(1):18-25. PubMed ID: 3500812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-reactivity between anti-cardiolipin, anti-high-density lipoprotein and anti-apolipoprotein A-I IgG antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome.
    Delgado Alves J; Kumar S; Isenberg DA
    Rheumatology (Oxford); 2003 Jul; 42(7):893-9. PubMed ID: 12730551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of autoantibodies against oxidatively modified low-density lipoprotein in essential hypertension: a biochemical signature of an enhanced in vivo low-density lipoprotein oxidation.
    Maggi E; Marchesi E; Ravetta V; Martignoni A; Finardi G; Bellomo G
    J Hypertens; 1995 Jan; 13(1):129-38. PubMed ID: 7759843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.